等待开盘 04-07 09:30:00 美东时间
-0.210
-1.21%
今日重点评级关注:Leerink Partners:维持Camp4 Therapeutics"跑赢大市"评级,目标价从8美元升至9美元;韦德布什:维持Arcus Biosciences"跑赢大市"评级,目标价从37美元升至41美元
04-06 16:27
Keybanc analyst Tim Rezvan maintains Infinity Natural (NYSE:INR) with a Overweight and raises the price target from $22 to $24.
04-02 19:28
https://www.sec.gov/Archives/edgar/data/2029118/000119312526137875/d133004ds3.htm
04-02 04:37
今日重点评级关注:瑞穗:维持RELMADA THERAPEUTICS"跑赢大市"评级,目标价从10美元升至19美元;奥本海默:维持Pelthos Therapeutics"跑赢大市"评级,目标价从60美元升至62美元
03-23 13:53
Citigroup analyst Paul Diamond maintains Infinity Natural (NYSE:INR) with a Buy and raises the price target from $18 to $24.
03-21 03:30
Gainers TMD Energy (AMEX:TMDE) stock rose 7.5% to $2.16 during Tuesday's after...
03-11 05:05
Companies Reporting Before The Bell • Ultralife (NASDAQ:ULBI) is likely to repo...
03-10 19:11
Infinity Natural Resources, Inc. ("Infinity" or the "Company") (NYSE: INR) today announced the successful completion of its transformational $1.2 billion acquisition of upstream and midstream assets in the Ohio Utica
02-24 05:32
Infinity Natural Resources, Inc. ("Infinity" or the "Company") (NYSE:INR) today announced it has acquired Chase Oil Corporation's ("Chase") working interest in Infinity's South Bend field in Pennsylvania in an all-stock
01-21 05:56
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
2025-12-10 10:33